1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow SPI-2012: new trials by email Literature Review of SPI-2012 trials Research Report on SPI-2012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy Eflapegrastim, Chemotherapy - Solid Tumors, Lymphoma | Phase 2 | Recruiting | Spectrum Pharmaceuticals, Inc | 40 | 2021-05-20 | 2026-10-28 |
| Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer SPI-2012, Pegfilgrastim, Docetaxel - Neutropenia | Phase 2 | Completed | Spectrum Pharmaceuticals, Inc | 148 | 2013-03-25 | 2022-04-15 |
Lymphoma (1) · Neutropenia (1)
Spectrum Pharmaceuticals, Inc (2)
United States (2) · Australia (1) · Georgia (1) · Hungary (1) · Israel (1) · Poland (1)